Corporate VCs back $49M round for dermatology player

John Carroll

Novo Ventures has stepped up to lead a $ 49 million for San Diego-based Thesan Pharmaceuticals, which is developing new drugs for conditions like acne and atopic dermatitis.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS